Nu-Med Plus, Inc. (NUMD): Entry into a Material Definitive Agreement
Nu-Med Plus, Inc. (NUMD) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-2.1 3 numd002_ex2-1.htm EXHIBIT 2.1 Exhibit 2.1 SHARE EXCHANGE AGREEMENT BY AND BETWEEN NU-MED PLUS, INC., A UTAH CORPORATION, AVID GOLD LTD, A PRIVATE LIMITED COMPANY FORMED IN AND UNDER THE LAWS OF ENGLAND AND WALES (COMPANY NO. 17095806) AND THE SHAREHOLDERS OF AVID GOLD LT
How this was made
The 30-second read
Why it matters
A newly disclosed share exchange agreement to acquire 100% of Avid Gold is a concrete corporate event that can re-rate the acquirer’s risk/valuation and create a path-dependent catalyst (signing → approvals/consents → closing).
Market read
This is a primary disclosure of a material definitive M&A agreement (share exchange), which can drive trading as investors digest deal structure and closing likelihood.
What to watch
Traders should focus on unregistered sales mechanics (Item 3.02), any termination rights, and whether there are material adverse change or consent requirements that could delay or derail closing.
Background
The filing is an SEC Form 8-K (Item 1.01) for Nu-Med Plus, Inc., attaching a share exchange agreement dated June 29, 2026.
Ticker impact
Nu-Med Plus, Inc. entered a material definitive share exchange agreement to acquire 100% of Avid Gold, making NUMD the acquirer.
Near-term volatility likely around deal terms/financing details and any closing-condition updates; direction depends on exchange ratio and perceived value (not provided in the excerpt).
This is a primary SEC filing (Item 1.01) indicating a fresh transaction, but the provided text excerpt does not include key economic terms (consideration, valuation, timing, conditions) needed for a directional call.
Market effects
Potential read-through to OTCQB microcap M&A activity and deal-structure norms (share exchange), but no sector-wide datapoints are provided.
Limited; transaction involves a UK private company (Avid Gold) and a US-listed OTCQB issuer (NUMD).
Low; cross-border element exists, but no macro/regulatory or large-industry linkage is disclosed in the excerpt.
Counterpoint
Without the exchange ratio, valuation, and financing/closing timeline, the market may discount the deal as low-information until full terms are reviewed.
Key entities
- public_companyNu-Med Plus, Inc.
OTCQB-quoted acquirer (symbol NUMD) entering a material definitive share exchange agreement.
- private_companyAvid Gold Ltd
UK private limited company whose 100% ownership is being acquired via the share exchange.
- counterpartiesAvid Gold Shareholders
Holders of all outstanding Avid Gold ordinary shares exchanging into NUMD securities per the agreement.
